Outset Medical announced today that it partnered with U.S. Renal Care to accelerate home hemodialysis in the U.S. The company entered into a multi-year agreement with U.S. Renal Care, the country’s largest privately held kidney care provider. They aim to utilize the Outset Tablo hemodialysis system as a home dialysis option in the 33 states […]
Outset Medical
Outset Medical stock soars on optimistic analyst outlook
Outset Medical shares are on the rise after BTIG analysts initiated coverage with a “Buy” rating for the home hemodialysis company. Shares of OM rose by more than 25% to $2.58 apiece in late-afternoon trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The optimistic outlook […]
Outset Medical stock plummets amid warning letter woes
Outset Medical has slashed its full-year revenue outlook as the maker of Tablo hemodialysis systems grapples with an FDA warning letter. The company now expects roughly $130 million in revenue in 2023 — down from its previous forecast of $144–150 million. It’s preliminary numbers show third-quarter sales up 9% year-over-year to $30.4 million. Cash, cash […]
Outset Medical pauses shipments for Tablo accessory as it awaits FDA clearance, stock sinks
Outset Medical shares took a hit after the at-home dialysis tech company announced a shipment hold within its second-quarter results. Shares of OM fell 12.7% at $16.91 apiece in after-hours trading after the release of the news yesterday evening. By midday today, OM shares had recovered slightly, down more than 10% to $17.27 apiece MassDevice‘s […]
Outset Medical stock sinks after it receives FDA warning letter
Outset Medical announced that it received a warning letter from the FDA related to its Tablo system. San Jose, California-based Outset previously disclosed an FDA Form 483 in its annual report in February. That FDA form identified four inspectional observations resulting from an inspection concluded on Feb. 10, 2023. From there, Outset provided a response […]
Outset Medical upgrades full-year guidance after strong Q1 performance
Outset Medical this week posted first-quarter results that beat the overall consensus on Wall Street. The San Jose, California-based dialysis company reported profit losses of $43.97 million, or 90¢ per share, on sales of $33.5 million, for the three months ended March 31, for a sales gain of 9.55% compared to Q1 2022. It had […]
Outset Medical beats The Street in Q4, reaffirms guidance
At-home hemodialysis technology developer Outset Medical (Nasdaq:OM) reported fourth-quarter results that topped the consensus forecast. Shares of OM, however, took a hit the morning following the company’s earnings call after the market closed yesterday. They dropped more than 12% to $25.02 apiece by midday. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest […]
The biggest medtech stock gainers, losers in 2022
In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most drastically. The MassDevice MedTech 100 Index, which includes stocks of the world’s largest medical device companies, reflects the performance of many in the medtech space. In a tough year for a lot of businesses, the Index […]
Axonics, Outset lead medtech space on Deloitte’s list of fastest growing companies
Deloitte today released its “North America Technology Fast 500” list of growing companies, including a handful of medtech firms. The list, which ranking of the fastest-growing North American companies across a range of sectors, included several “Life Sciences” outfits. Immunology company Vir Biotechnology led the way in first place on the list. Axonics (Nasdaq:AXNX) represented […]
Outset Medical skyrockets on Q3 revenue beat, raises full-year guidance
Outset Medical (Nasdaq:OM) this week posted third-quarter results that were in line with earnings estimates and beat the revenue consensus on Wall Street. The San Jose, California-based home hemodialysis device maker reported net losses of $40.8 million, or –85¢ per share, on sales of $27.8 million for the three months ended Sept. 30, for a […]
Outset Medical secures debt financing of up to $300M
Outset Medical (Nasdaq: OM) today announced two senior secured credit facilities with investment affiliates managed by SLR Capital Partners. Collectively, the facilities provide for up to $300 million in borrowing for the maker of the Tablo Hemodialysis System. The facilities include an up-to-$250-million term loan facility and an up-to-$50-million asset-based revolving credit facility. Outset drew $100 […]